Financials Fuse Medical, Inc.

Equities

FZMD

US36113U1016

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 10:54:05 2024-04-18 am EDT 5-day change 1st Jan Change
0.0988 USD +3.95% Intraday chart for Fuse Medical, Inc. 0.00% -14.09%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 36.12 21.07 13.2 30.2 10.55
Enterprise Value (EV) 1 36.9 21.87 13.79 32.42 12.75
P/E ratio 8.6 x -6 x -9.22 x -19 x 3.75 x
Yield - - - - -
Capitalization / Revenue 1.37 x 0.92 x 0.62 x 1.48 x 0.57 x
EV / Revenue 1.4 x 0.95 x 0.64 x 1.59 x 0.68 x
EV / EBITDA -19.3 x -6.61 x -14.9 x -15.2 x -18.8 x
EV / FCF 24.4 x 16.5 x 9.76 x -82.1 x 11.8 x
FCF Yield 4.1% 6.07% 10.2% -1.22% 8.46%
Price to Book 23.9 x -17.2 x -6.25 x -8.81 x -33.9 x
Nbr of stocks (in thousands) 72,222 70,222 70,222 70,222 70,322
Reference price 2 0.5001 0.3000 0.1880 0.4300 0.1500
Announcement Date 3/21/19 3/30/20 3/31/21 3/31/22 4/14/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 26.41 26.34 22.9 21.4 20.41 18.64
EBITDA 1 1.027 -1.909 -3.311 -0.9238 -2.128 -0.6777
EBIT 1 1.013 -1.958 -3.418 -1.028 -2.196 -0.8151
Operating Margin 3.83% -7.43% -14.92% -4.8% -10.75% -4.37%
Earnings before Tax (EBT) 1 0.6997 3.571 -2.535 -1.414 -1.57 3.122
Net income 1 0.6997 3.958 -3.316 -1.432 -1.588 3.098
Net margin 2.65% 15.02% -14.48% -6.69% -7.78% 16.62%
EPS 2 0.0400 0.0582 -0.0500 -0.0204 -0.0226 0.0400
Free Cash Flow 1 0.195 1.512 1.327 1.412 -0.395 1.079
FCF margin 0.74% 5.74% 5.8% 6.6% -1.94% 5.79%
FCF Conversion (EBITDA) 18.98% - - - - -
FCF Conversion (Net income) 27.87% 38.2% - - - 34.82%
Dividend per Share - - - - - -
Announcement Date 4/6/18 3/21/19 3/30/20 3/31/21 3/31/22 4/14/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 2.76 0.78 0.8 0.59 2.23 2.2
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.688 x -0.4103 x -0.2426 x -0.6358 x -1.048 x -3.245 x
Free Cash Flow 1 0.19 1.51 1.33 1.41 -0.4 1.08
ROE (net income / shareholders' equity) 53.5% -121% -2,712% 85.9% 57.3% -166%
ROA (Net income/ Total Assets) 3.26% -5.91% -10.5% -3.59% -7.68% -2.68%
Assets 1 21.46 -66.97 31.48 39.91 20.67 -115.8
Book Value Per Share 2 -0.1200 0.0200 -0.0200 -0.0300 -0.0500 -0
Cash Flow per Share 2 0.0100 0.0100 0.0200 0.0200 0.0100 0
Capex 1 0.02 0.04 0.02 0.02 - -
Capex / Sales 0.08% 0.16% 0.07% 0.1% - -
Announcement Date 4/6/18 3/21/19 3/30/20 3/31/21 3/31/22 4/14/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. FZMD Stock
  4. Financials Fuse Medical, Inc.